The Hornet That Wasn't: What the Data Shows About Spain's Invasive Vespa velutina
When the yellow-legged hornet, Vespa velutina, crossed into Spain, the headlines that followed painted a picture of a creature more monster than insect. An Asian species spreading through European skies, stinging people to death — the story wrote itself. But the data tells a different story.
Researchers at the University of the Balearic Islands have spent years trying to measure what has actually happened to human mortality since this sleek, amber-footed predator established itself across Spanish territory. Their findings, published in March in the Journal of Medical Entomology, are striking — not for what they confirm, but for what they don't.
Sifting through officially certified death records from Spain's National Statistical Institute spanning 1999 to 2023, the team identified 118 deaths attributed to contact with bees, wasps, and hornets across that entire 24-year window. That period brackets both the time before V. velutina arrived and the years of its steady inland expansion. The pattern they expected — rising deaths mirroring the hornet's spread — simply didn't materialise.
Mortality rates showed no upward trend over time. No seasonal spike. No clear difference between indoor and outdoor encounters. Men and women were equally affected. And in regions where V. velutina has dug in most deeply, death rates weren't measurably higher than elsewhere. The one tentative signal in the data — a possible elevated risk among adults aged 60 to 99 — wasn't strong enough to draw firm conclusions.
"The most striking finding was the contrast between our results and the prevailing media narrative," says postdoctoral researcher Cayetano Herrera, who co-authored the study with colleague María del Mar Leza Salord. More hornets, the logic goes, should mean more stings, which should mean more deaths. That chain of reasoning sounds sensible. The evidence just doesn't support it — at least not yet, and not at population scale.
Across Europe, V. velutina's apparent contribution to stinging-insect mortality looks broadly comparable to that of native bees and wasps, once exposure rates are accounted for. Like all Hymenoptera, it becomes acutely dangerous through two routes: triggering severe anaphylaxis in people with pre-existing allergies, or delivering enough venom volume through mass stinging to overwhelm the body's defences. Neither scenario is unique to this species.
The study's limitations are honest and openly acknowledged. Spain's mortality data bundles all bee, wasp, and hornet deaths into a single category — a blunt instrument when researchers are trying to isolate the fingerprint of one invasive species within that group. To compensate, the team compared death rates across regions where the hornet is established against those where it hasn't yet arrived, and reconstructed the species' geographic spread using scientific literature and regional records to fill the official gaps.
Then, in 2025, a cluster of high-profile deaths in Spain reignited public anxiety — exactly the kind of event that makes rigorous, longitudinal data more important, and harder to interpret in the immediate moment.
None of this means V. velutina deserves a clean bill of health. A disturbed nest is a serious hazard. Allergic individuals face genuine risk from any stinging insect, this one included. And the hornet's impact on honeybee colonies and wild pollinator communities is well-documented and ecologically significant — it hunts foraging bees with surgical efficiency, hovering outside hive entrances and picking them off in flight. That pressure on managed and wild bee populations ripples outward into the pollination networks underpinning both agriculture and natural ecosystems.
Herrera and Leza Salord are also clear that population-level deaths are the rarest and most extreme clinical outcome of any Hymenoptera encounter. What the mortality statistics can't capture is the broader burden — the emergency room visits, the systemic allergic reactions, the healthcare demand that builds quietly beneath the fatal threshold. Future research, the authors argue, needs to focus precisely there: tracking allergic reactions, mapping regional risk variation, and integrating clinical data with ecological surveillance.
Climate projections add another layer of complexity. V. velutina's range is expected to keep expanding as temperatures shift, potentially moving the species into territories and human population centres where neither the insect nor local medical infrastructure have yet encountered each other.
"While we found no significant association between the presence of the species and mortality rates, this does not mean the situation is static," Herrera says.
The science, in other words, is asking for proportionate attention rather than panic — vigilance grounded in evidence, not anxiety fed by headlines. A species worth watching closely, for reasons that stretch well beyond the sting.